Survival study of Parkinson disease in Olmsted County, Minnesota

Archives of Neurology

Volumn 60, Issue 1, 2003, Pages 91-96

  Elbaz, Alexis ^a   Bower, James H ^a   Peterson, Brett J ^a   Maraganore, Demetrius M ^a   McDonnell, Shannon K ^a   Ahlskog, J Eric ^a   Schaid, Daniel J ^a   Rocca, Walter A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; COMPARATIVE STUDY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TREMOR;

EID: 0037225268     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.1.91     Document Type: Article

References (31)

1. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology. 1967;17:427-442.
2. Ben-Shlomo Y, Marmot MG. Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology? J Neurol Neurosurg Psychiatry. 1995;58:293-299.
3. Clarke CE. Does levodopa therapy delay death in Parkinson's disease? a review of the evidence. Mov Disord 1995;10:250-256.
4. Bennett DA, Beckett LA, Murray AM, et al, Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med. 1996;334:71-76.
5. Louis ED, Marder K, Cote L, Tang M, Mayeux R. Mortality from Parkinson disease. Arch Neurol. 1997;54:260-264.
6. Diamond SG, Markham CH, Hoehn MM, McDowell FH, Muenter MD. An examination of male-female differences in progression and mortality of Parkinson's disease. Neurology. 1990;40:763-766.
7. Berger K, Breteler MMB, Helmer C, et al, for the Neurologic Diseases in the Elderly Research Group. Prognosis with Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurology. 2000;54(suppl 5):S24-S27.
8. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology. 1999;52:1214-1220.
9. Benedetti MD, Bower JH, Maraganore DM, et al. Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology. 2000;55:1350-1358.
10. Elbaz A, Peterson BJ, Yang P, et al. Nonfatal cancer preceding Parkinson's disease: a case-control study. Epidemiology. 2002;13:157-164.
11. Commission on Professional and Hospital Activities. Hospital Adaptation of ICDA-H-ICDA. 2nd ed. Ann Arbor, Mich: Commission on Professional and Hospital Activities; 1973.
12. Last JM, ed. A Dictionary of Epidemiology, 4th ed. New York, NY: Oxford University Press; 2001.
13. Schoenberg BS. Descriptive epidemiology. In: Schoenberg BS, ed. Neurological Epidemiology: Principles and Clinical Applications. Vol 19. New York, NY: Raven Press; 1978:17-42. Advances in Neurology.
14. Shopland DR. Cigarette smoking as a cause of cancer. In: Harras A, Edwards BK, Blot WJ, Ries LAG, eds. Cancer Rates and Risks. Bethesda, Md: National Cancer Institute; 1996:67-72. NIH Publication 96-691.
15. Uitti RJ, Ahlskog JE, Maraganore DM, et al. Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project. Neurology. 1993;43:1918-1926.
16. Breslow NE, Day NE. Statistical Methods in Cancer Research. Volume 2 - The Design and Analysis of Cohort Studies. Lyon, France: International Agency for Research on Cancer; 1987. IARC Scientific Publications 82.
17. Therneau TM, Gambsch PM, eds. Modeling Survival Data: Extending the Cox Model. New York, NY: Springer-Verlag; 2000.
18. SAS Institute Inc. SAS Proprietary Software Release 8.02. Cary, NC: SAS Institute Inc; 1999.
19. Ebmeier KP, Calder SA, Crawford JR, Stewart L, Besson JA, Mutch WJ. Parkinson's disease in Aberdeen: survival after 3.5 years. Acta Neurol Scand. 1990;81:294-299.
20. Morens DM, Davis JW, Grandinetti A, Ross GW, Popper JS, White LR. Epidemiologic observations on Parkinson's disease: incidence and mortality in a prospective study of middle-aged men. Neurology. 1996;46:1044-1050.
21. Nobrega FT, Glattre E, Kurland LT, Okazaki H. Comments on the epidemiology of parkinsonism including prevalence and incidence statistics for Rochester, Minnesota, 1935-1966. In: Barbeau A, Brunette JR, eds. Proceedings of the International Congress of Neuro-Genetics and Neuro-Ophthalmology. Amsterdam, the Netherlands: Excerpta Medica; 1967:474-485. International Congress Series 175.
22. Rajput AH, Offord KP, Beard CM, Kurland LT. Epidemiology of parkinsonism: incidence, classification, and mortality. Ann Neurol. 1984;16:278-282.
23. Wermuth L, Stenager EN, Stenager E, Boldsen J. Mortality in patients with Parkinson's disease. Acta Neurol Scand. 1995;92:55-58.
24. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology. 1997;49:1284-1288.
25. Checkoway H, Nelson LM. Epidemiologic approaches to the study of Parkinson's disease etiology. Epidemiology. 1999;10:327-336.
26. Ross GW, Abbott RD, Petrovitch H, et al. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA. 2000;283:2674-2679.
27. Hernán MA, Zhang SM, Rueda-deCastro AM, Colditz GA, Speizer FE, Ascherio A. Cigarette smoking and the incidence of Parkinson's disease in two prospective studies. Ann Neurol. 2001;50:780-786.
28. Sackett DL. Bias in analytic research. J Chronic Dis. 1979;32:51-63.
29. Ellenberg JH. Differential postmorbidity mortality in observational studies of risk factors for neurologic disorders. Neuroepidemiology. 1994;13:187-194.
30. Morens DM, Grandinetti A, Davis JW, Ross GW, White LR, Reed D. Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson disease. Am J Epidemiol. 1996;144:400-404.
31. Paulson GW, Gill WM. Are death certificates reliable to estimate the incidence of Parkinson's disease? Mov Disord. 1995;10:678.